Swift Run Capital Management’s CervoMed CRVO Stock Holding History

Swift Run Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-267	Closed	-$17K	–	45
2020 Q3	$17K	Buy	+267	New	+$20.3K	0.03%	46
2020 Q2	–	Sell	-194	Closed	-$5K	–	52
2020 Q1	$5K	Hold	194	–	–	0.01%	58
2019 Q4	$7K	Hold	194	–	–	0.01%	33
2019 Q3	$27K	Hold	194	–	–	0.03%	38
2019 Q2	$41K	Hold	194	–	–	0.04%	40
2019 Q1	$54K	Hold	194	–	–	0.05%	41
2018 Q4	$29K	Sell	194 -1,893	-91%	-$646K	0.03%	35
2018 Q3	$1.01M	Sell	2,087 -58	-3%	-$27K	0.88%	20
2018 Q2	$1.1M	Sell	2,145 -84	-4%	-$49.7K	0.96%	20
2018 Q1	$1.37M	Buy	2,229 +1,613	+262%	+$1.4M	0.98%	23
2017 Q4	$820K	Hold	616	–	–	0.51%	26
2017 Q3	$1.15M	Hold	616	–	–	0.61%	30
2017 Q2	$1.61M	Buy	+616	New	+$1.98M	0.93%	24

Other funds holding CRVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Swift Run Capital Management's CRVO Position: Q4 2020 in Review

Swift Run Capital Management sold out of CervoMed (CRVO) in Q4 2020, closing a stake of 267 shares — an estimated $17K sold.

Swift Run Capital Management first reported a position in CRVO in Q2 2017 and held it in 13 quarters. The position peaked at $1.61M in Q2 2017. 21 funds tracked by Wall St. Rank hold CRVO as of Q4 2020.

Swift Run Capital Management reported no remaining CervoMed position as of Q4 2020 after selling out during the quarter.
Swift Run Capital Management sold 267 CervoMed shares in Q4 2020, an estimated $17K.
Swift Run Capital Management first reported a position in CervoMed in Q2 2017 and held it in 13 quarters.
Swift Run Capital Management's CervoMed position peaked at $1.61M in Q2 2017.
21 funds tracked by Wall St. Rank held CervoMed as of Q4 2020.

Based on Swift Run Capital Management's 13F filing for Q4 2020, filed 2 Feb 2021.